Literature DB >> 10626738

Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene.

I J Brogan1, N Khan, K Isaac, J A Hutchinson, V Pravica, I V Hutchinson.   

Abstract

We have characterized 5 novel, single-nucleotide polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor (VEGF) gene. Transitions C --> A at nucleotide position -2578 relative to the translation start site, T --> C at position -1455, G --> A at position -1154, G --> C at position -1001, and C --> T at position -7 were observed. In addition, individuals with the A allele at position -2578 also had an insertion of 18 nucleotides, whereas CC homozygotes did not contain this insertion. We have described the frequency distribution of the polymorphic alleles in the population of healthy volunteers and are investigating the functional significance of the 18-nucleotide insertion and of the single-nucleotide polymorphisms on VEGF gene expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626738     DOI: 10.1016/s0198-8859(99)00132-9

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  72 in total

Review 1.  Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.

Authors:  Z Tang; R P Tracy
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

2.  Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis.

Authors:  Alice Brockington; Janine Kirby; Dean Eggitt; Emma Schofield; Chris Morris; Claire E Lewis; Paul G Ince; Pamela J Shaw
Journal:  Neurogenetics       Date:  2005-03-18       Impact factor: 2.660

Review 3.  Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

Authors:  A R L Medford; A B Millar
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

4.  The -2549 insertion/deletion polymorphism in the promoter region of the VEGFA gene in couples with idiopathic recurrent spontaneous abortion.

Authors:  Nina Pereza; Saša Ostojić; Anamarija Smirčić; Alenka Hodžić; Miljenko Kapović; Borut Peterlin
Journal:  J Assist Reprod Genet       Date:  2015-10-16       Impact factor: 3.412

5.  VEGF and IL-4 gene variability and its association with the risk of coronary heart disease in north Indian population.

Authors:  R C Sobti; Nishi Maithil; Hitender Thakur; Yashpaul Sharma; K K Talwar
Journal:  Mol Cell Biochem       Date:  2010-04-04       Impact factor: 3.396

6.  Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.

Authors:  T Langsenlehner; E-M Thurner; W Renner; A Gerger; K S Kapp; U Langsenlehner
Journal:  Strahlenther Onkol       Date:  2014-01-18       Impact factor: 3.621

7.  Association of vascular endothelial growth factor C-634 g polymorphism in taiwanese children with Kawasaki disease.

Authors:  K-C Hsueh; Y-J Lin; J-S Chang; L Wan; Y-H Tsai; C-H Tsai; C-P Chen; F-J Tsai
Journal:  Pediatr Cardiol       Date:  2007-09-15       Impact factor: 1.655

8.  VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab.

Authors:  Anna Luisa Di Stefano; Marianne Labussiere; Giuseppe Lombardi; Marica Eoli; Donata Bianchessi; Francesco Pasqualetti; Patrizia Farina; Stefania Cuzzubbo; Jaime Gallego-Perez-Larraya; Blandine Boisselier; Francois Ducray; Caroline Cheneau; Arrigo Moglia; Gaetano Finocchiaro; Yannick Marie; Amithys Rahimian; Khe Hoang-Xuan; Jean Yves Delattre; Karima Mokhtari; Marc Sanson
Journal:  J Neurooncol       Date:  2014-12-07       Impact factor: 4.130

9.  Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer.

Authors:  Hayra de Andrade Vieira-Monteiro; Daniely Regina Freitas-Alves; Marcelo Sobral-Leite; João Marcos de Azevedo Delou; Sheyla Maria Torres Goulart-Citrangulo; Camila Telles do Nascimento; Thales Nascimento E Castro; Sérgio Koifman; Jamila Alessandra Perini; Rosane Vianna-Jorge
Journal:  Cancer Biol Ther       Date:  2016-06-02       Impact factor: 4.742

10.  Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients.

Authors:  A Abajo; J Rodriguez; N Bitarte; R Zarate; V Boni; M Ponz; A Chopitea; E Bandres; J Garcia-Foncillas
Journal:  Br J Cancer       Date:  2010-10-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.